EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
TSX:EXE - Toronto Stock Exchange - CA30224T8639 - Common Stock - Currency: CAD
EXE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 17 industry peers in the Health Care Providers & Services industry. EXE scores excellent on profitability, but there are some minor concerns on its financial health. EXE has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year EXE was profitable.
EXE had a positive operating cash flow in the past year.
Each year in the past 5 years EXE has been profitable.
In the past 5 years EXE always reported a positive cash flow from operatings.
1.2 Ratios
EXE has a Return On Assets of 10.45%. This is amongst the best in the industry. EXE outperforms 94.12% of its industry peers.
EXE has a Return On Equity of 60.48%. This is amongst the best in the industry. EXE outperforms 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 19.69%, EXE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
EXE had an Average Return On Invested Capital over the past 3 years of 11.40%. This is above the industry average of 8.02%.
The last Return On Invested Capital (19.69%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.45% | ||
| ROE | 60.48% | ||
| ROIC | 19.69% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
The Profit Margin of EXE (5.13%) is better than 82.35% of its industry peers.
EXE's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 7.59%, EXE is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
EXE's Operating Margin has improved in the last couple of years.
EXE has a Gross Margin of 13.74%. This is in the lower half of the industry: EXE underperforms 76.47% of its industry peers.
EXE's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.59% | ||
| PM (TTM) | 5.13% | ||
| GM | 13.74% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
EXE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, EXE has more shares outstanding
EXE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, EXE has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.88 indicates that EXE is not a great score, but indicates only limited risk for bankruptcy at the moment.
EXE has a better Altman-Z score (2.88) than 76.47% of its industry peers.
EXE has a debt to FCF ratio of 2.88. This is a good value and a sign of high solvency as EXE would need 2.88 years to pay back of all of its debts.
EXE has a Debt to FCF ratio of 2.88. This is amongst the best in the industry. EXE outperforms 82.35% of its industry peers.
A Debt/Equity ratio of 2.10 is on the high side and indicates that EXE has dependencies on debt financing.
The Debt to Equity ratio of EXE (2.10) is worse than 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.1 | ||
| Debt/FCF | 2.88 | ||
| Altman-Z | 2.88 |
ROIC/WACC3.01
WACC6.55%
2.3 Liquidity
EXE has a Current Ratio of 0.83. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
EXE has a Current ratio (0.83) which is comparable to the rest of the industry.
EXE has a Quick Ratio of 0.83. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
EXE has a Quick ratio (0.83) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
EXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 115.64%, which is quite impressive.
The Earnings Per Share has been growing by 22.74% on average over the past years. This is a very strong growth
The Revenue has grown by 12.36% in the past year. This is quite good.
Measured over the past years, EXE shows a small growth in Revenue. The Revenue has been growing by 5.31% on average per year.
EPS 1Y (TTM)115.64%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%105.28%
Revenue 1Y (TTM)12.36%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%11.82%
3.2 Future
EXE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.59% yearly.
EXE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.61% yearly.
EPS Next Y-4.22%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
EPS Next 5Y7.59%
Revenue Next Year5.78%
Revenue Next 2Y4.84%
Revenue Next 3Y4.08%
Revenue Next 5Y2.61%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 16.52, the valuation of EXE can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of EXE indicates a rather cheap valuation: EXE is cheaper than 88.24% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.33, EXE is valued a bit cheaper.
With a Price/Forward Earnings ratio of 17.08, EXE is valued on the expensive side.
EXE's Price/Forward Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 88.24% of the companies in the same industry.
EXE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.52 | ||
| Fwd PE | 17.08 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXE indicates a rather cheap valuation: EXE is cheaper than 88.24% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, EXE is valued a bit cheaper than 70.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.76 | ||
| EV/EBITDA | 8.75 |
4.3 Compensation for Growth
The excellent profitability rating of EXE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.73
EPS Next 2Y4.74%
EPS Next 3Y7.81%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.81%, EXE has a reasonable but not impressive dividend return.
EXE's Dividend Yield is rather good when compared to the industry average which is at 3.45. EXE pays more dividend than 88.24% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.51, EXE pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.81% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of EXE decreased in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
EXE pays out 53.21% of its income as dividend. This is a bit on the high side, but may be sustainable.
EXE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP53.21%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
TSX:EXE (4/22/2025, 7:00:00 PM)
13.05
-0.07 (-0.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners20.16%
Inst Owner ChangeN/A
Ins Owners14.21%
Ins Owner ChangeN/A
Market Cap1.09B
Analysts74
Price Target13.81 (5.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.81% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP53.21%
Div Incr Years0
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.17%
PT rev (3m)23.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.58%
EPS NY rev (3m)-1.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.52 | ||
| Fwd PE | 17.08 | ||
| P/S | 0.75 | ||
| P/FCF | 10.76 | ||
| P/OCF | 7.62 | ||
| P/B | 8.8 | ||
| P/tB | 317.52 | ||
| EV/EBITDA | 8.75 |
EPS(TTM)0.79
EY6.05%
EPS(NY)0.76
Fwd EY5.86%
FCF(TTM)1.21
FCFY9.3%
OCF(TTM)1.71
OCFY13.13%
SpS17.49
BVpS1.48
TBVpS0.04
PEG (NY)N/A
PEG (5Y)0.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.45% | ||
| ROE | 60.48% | ||
| ROCE | 26.05% | ||
| ROIC | 19.69% | ||
| ROICexc | 27.55% | ||
| ROICexgc | 45.64% | ||
| OM | 7.59% | ||
| PM (TTM) | 5.13% | ||
| GM | 13.74% | ||
| FCFM | 6.94% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexcg growth 3Y72.34%
ROICexcg growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.1 | ||
| Debt/FCF | 2.88 | ||
| Debt/EBITDA | 1.81 | ||
| Cap/Depr | 125.84% | ||
| Cap/Sales | 2.86% | ||
| Interest Coverage | 9.93 | ||
| Cash Conversion | 99.37% | ||
| Profit Quality | 135.21% | ||
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | 2.88 |
F-Score8
WACC6.55%
ROIC/WACC3.01
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)115.64%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%105.28%
EPS Next Y-4.22%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
EPS Next 5Y7.59%
Revenue 1Y (TTM)12.36%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%11.82%
Revenue Next Year5.78%
Revenue Next 2Y4.84%
Revenue Next 3Y4.08%
Revenue Next 5Y2.61%
EBIT growth 1Y76.64%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year-9.93%
EBIT Next 3Y-0.13%
EBIT Next 5Y0.3%
FCF growth 1Y195.82%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y516.9%
OCF growth 3Y31.32%
OCF growth 5Y26.02%